315 related articles for article (PubMed ID: 27760683)
1. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices.
Sevelius JM; Deutsch MB; Grant R
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21105. PubMed ID: 27760683
[TBL] [Abstract][Full Text] [Related]
2. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
Sevelius JM; Keatley J; Calma N; Arnold E
Glob Public Health; 2016; 11(7-8):1060-75. PubMed ID: 26963756
[TBL] [Abstract][Full Text] [Related]
3. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.
Grant RM; Sevelius JM; Guanira JV; Aguilar JV; Chariyalertsak S; Deutsch MB
J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 3(Suppl 3):S226-9. PubMed ID: 27429187
[TBL] [Abstract][Full Text] [Related]
4. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies.
Wilson EC; Turner CM; Arayasirikul S; Lightfoot M; Scheer S; Raymond HF; Liu A
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25539. PubMed ID: 32602642
[TBL] [Abstract][Full Text] [Related]
5. Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review.
Dang M; Scheim AI; Teti M; Quinn KG; Zarwell M; Petroll AE; Horvath KJ; John SA
AIDS Patient Care STDS; 2022 Jun; 36(6):236-248. PubMed ID: 35687813
[TBL] [Abstract][Full Text] [Related]
6. Caring for the whole person: transgender-competent HIV pre-exposure prophylaxis as part of integrated primary healthcare services in Vietnam.
Doan AH; Vu CMH; Nguyen TT; Green KE; Phan HTT; Janamnuaysook R; Vu BN; Le TM; Do KQ; Tran TT; Ngo TM; Basu L; Tran LK; Humeau Z
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25996. PubMed ID: 36225133
[TBL] [Abstract][Full Text] [Related]
7. Pre-Exposure Prophylaxis in Trans Populations: Providing Gender-Affirming Prevention for Trans People at High Risk of Acquiring HIV.
Deutsch MB
LGBT Health; 2018 Oct; 5(7):387-390. PubMed ID: 30272493
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
[TBL] [Abstract][Full Text] [Related]
9. Barriers and Facilitators to PrEP Initiation and Adherence Among Transgender and Gender Non-Binary Individuals in Southern California.
Watson CW; Pasipanodya E; Savin MJ; Ellorin EE; Corado KC; Flynn RP; Opalo C; Lampley E; Henry BL; Blumenthal J; Bolan R; Morris S; Moore DJ
AIDS Educ Prev; 2020 Dec; 32(6):472-485. PubMed ID: 33779208
[TBL] [Abstract][Full Text] [Related]
10. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
[TBL] [Abstract][Full Text] [Related]
11. Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication.
Bass SB; Kelly PJ; Brajuha J; Gutierrez-Mock L; Koester K; D'Avanzo P; Sevelius J
BMC Public Health; 2022 Jan; 22(1):17. PubMed ID: 34991548
[TBL] [Abstract][Full Text] [Related]
12. The wisdom of mistrust: qualitative insights from transgender women who participated in PrEP research in Lima, Peru.
Perez-Brumer A; Naz-McLean S; Huerta L; Salazar X; Lama JR; Sanchez J; Silva-Santisteban A; Reisner SL; Mayer KH; Clark JL
J Int AIDS Soc; 2021 Sep; 24(9):e25769. PubMed ID: 34569152
[TBL] [Abstract][Full Text] [Related]
13. Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations.
Restar A; Minalga BJ; Quilantang MI; Adamson T; Dusic E; van der Merwe LA; Millet G; Rosadiño D; Laguing T; Lett E; Everhart A; Phillips G; Janamnuaysook R; Seekaew P; Baker K; Ashley F; Wickersham J; Wallace SE; Operario D; Gamarel KE
Curr HIV/AIDS Rep; 2023 Jun; 20(3):160-169. PubMed ID: 37012537
[TBL] [Abstract][Full Text] [Related]
14. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco.
Cahill SR; Keatley J; Wade Taylor S; Sevelius J; Elsesser SA; Geffen SR; Wang T; Mayer KH
AIDS Care; 2020 May; 32(5):585-593. PubMed ID: 31482726
[TBL] [Abstract][Full Text] [Related]
15. HIV Antiretroviral Treatment and Pre-exposure Prophylaxis in Transgender Individuals.
Poteat TC; Radix A
Drugs; 2020 Jul; 80(10):965-972. PubMed ID: 32451925
[TBL] [Abstract][Full Text] [Related]
16. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
[TBL] [Abstract][Full Text] [Related]
17. HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review.
Pacífico de Carvalho N; Mendicino CCP; Cândido RCF; Alecrim DJD; Menezes de Pádua CA
AIDS Care; 2019 Oct; 31(10):1234-1240. PubMed ID: 31043069
[TBL] [Abstract][Full Text] [Related]
18. Transgender Women's Concerns and Preferences on Potential Future Long-Acting Biomedical HIV Prevention Strategies: The Case of Injections and Implanted Medication Delivery Devices (IMDDs).
Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman SG; Footer KHA; D'Aquila RT; Carballo-Diéguez A; Hope TJ
AIDS Behav; 2020 May; 24(5):1452-1462. PubMed ID: 31654172
[TBL] [Abstract][Full Text] [Related]
19. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.
Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S
AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
